Fewer than a quarter of breast cancer patients and a third of ovarian cancer patients diagnosed between 2013 and 2014 in two states underwent genetic testing for cancer-associated mutations, according to a new study.
Ovarian cancer patients undertested for mutations that could guide clinical care
